Advisors Asset Management Inc. cut its stake in shares of AbbVie Inc. (NYSE: ABBV) by 3.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,091 sh
Aviso Financial Inc. increased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 4.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SE
Associated Banc Corp raised its holdings in AbbVie Inc. (NYSE: ABBV) by 1.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned
NORTH CHICAGO, Ill. , Nov. 24, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025.
These dividend stocks represent the communications services, energy, financial services, healthcare, and real estate sectors. All of them have attractive dividend yields.
JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.
American Century Companies Inc. increased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 11.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,42
AXQ Capital LP raised its stake in AbbVie Inc. (NYSE: ABBV) by 21.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The f
Bank Julius Baer and Co. Ltd Zurich cut its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 3.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Excha
AlphaCore Capital LLC increased its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 17.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities an
Insightful Analysis of Jeff Auxier (Trades, Portfolio)'s Third Quarter 2025 13F Filing Jeff Auxier (Trades, Portfolio) recently submitted the 13F filing for th

2 Dividend Stocks to Hold Through Any Market Cycle

12:23pm, Wednesday, 19'th Nov 2025
Trying to build a portfolio that can survive recessions, inflation, and market volatility is one of the biggest challenges any investor can face.
ABBV rebounds after its Q3 dip as strong immunology and neuroscience growth offset Humira erosion and aesthetics weakness.
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, the industry is starting to feel the weight of expectations, and many of the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE